Opposition 91300248
OtherUSPTO
Opposition 91300248 at USPTO between Provepharm Life Solutions and Celgene Corporation, over the mark LYMZENTY, filed Jul 10, 2025. Status in the office record: other.
- Status
- Other
- Result
- Other
- Filed
- Jul 10, 2025
- Marks involved
- 2
Parties
Who is involved
The parties as named in the office record.
Timeline
How the case has moved
Dates from the USPTO record and the LYMZENTY filing.
LYMZENTY filed
Application 98435992 filed at the USPTO.Opposition filed
Provepharm Life Solutions started opposition 91300248 at USPTO against LYMZENTY.
Marks
Marks involved
1 contested mark, 1 mark the challenger relies on.
API
Get this data via the API
Every fact on this page comes from the Signa API. Track oppositions and cancellations on any mark with one request.
GET/v1/proceedings/{id}Parties, dates, outcome and every mark in the case
GET/v1/proceedings?trademark_id={trademark_id}Every proceeding on a mark
GET /v1/proceedings/{id}
ID=prc_fc69d5eb-7031-4ae1-b52c-6f73d202ad94
curl https://api.signa.so/v1/proceedings/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"Response
{
"id": "prc_fc69d5eb-7031-4ae1-b52c-6f73d202ad94",
"object": "proceeding",
"proceeding_type": "opposition",
"proceeding_number": "91300248",
"status": "other",
"office_code": "US",
"filed_date": "2025-07-10",
"parties": [
{
"name": "Provepharm Life Solutions",
"role": "opponent"
},
{
"name": "Celgene Corporation",
"role": "respondent"
}
]
}